Status: Recruiting
Lanadelumab in Long-term Prophylaxis of Acquired Angioedema
use of lanadelumab in patients with acquired angioedema
Participants needed: 5
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Bernstein Clinical Research CenterUpdated: Feb 25, 2025Locations: 1
Eligibility criteria
A diagnosis of AAE with recurrent attacks without urticaria (decreased C1INH fun... [+1]
History of anaphylaxis or hypersensitivity to biologics [+4]